Skip to main content
Screener/Healthcare/Biotechnology

TCRX — TScan Therapeutics, Inc.

NASDAQ
$1.24+0.08 (+6.90%)
Micro CapPenny StockUnder $5Healthcare
$0.88
$2.57
$1.14
$1.24
EPS (TTM)$-1.00
P/E Ratio-1.26
Dividend Yield—
Market Cap$73.1M
Volume505K
Prev Close$1.16
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$2.6M-$23.0M$-0.1871.8%-895.1%
Q3 '25$2.5M-$35.7M$-0.2869.5%-1422.1%
Q2 '25$3.1M-$37.0M$-0.28100.0%-1201.3%
Q1 '25$2.2M-$34.1M$-0.26100.0%-1571.9%
Q4 '24$665K-$35.8M$-0.30100.0%-5384.8%
Q3 '24$1.0M-$29.9M$-0.25100.0%-2849.1%
Q2 '24$536K-$31.7M$-0.28100.0%-5906.9%
Q1 '24$566K-$30.1M$-0.32100.0%-5325.4%
Get Your Daily Market Recap
TCRX Stock Price, Chart & Analysis